Health Condition 1: J205- Acute bronchitis due to respiratory syncytial virus
Conditions
Interventions
Intervention1: HERBOVIR Syrup: Dose : 10 ml of HERBOVIR syrup three times daily in the
morning (After Breakfast), after noon (Post lunch) and in night after dinner
Route: Orally
Duration: Three time
Sponsors
VENKAT PHARMA
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects aged 18-65 years of age and of either sex 2. subjects who were disposed to give consent to the study and willing for follow-up 3. Subjects who are willing to sign ICF 4. Clinical signs and symptoms of an URTI with a duration of up to 24 hours accompanied with or without fever 37.5 C (axillary body temperature) or higher 5. At least 1 of 3 types of URTI symptoms â?? Nasal (plugged nose, runny nose, sneezing), Pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), Cough (ordinary cough without suspicion of acute lower respiratory tract disease). At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney,or less active 6. Not be in need of hospitalized medical care at screening
Exclusion criteria
Exclusion criteria: 1. Age less than 18 years and more than 65 years 2. Pregnancy 3. Severe or complicated course of URTI. 4. Signs of acute lower respiratory tract disease. 5. Daily use of antibiotics, steroids and cytotoxic agents. 6. Any uncontrolled systemic disease, infection 7. Those with serious Cardiovascular, Cerebrovascular, Respiratory, Liver or Renal disease• or any other disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in the Wisconsin Upper Respiratory Symptom SurveyTimepoint: Day 0 to Day 7 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Adverse events (AEs), â?¢ frequency and severity Number of subjects who discontinue study due to adverse events â?¢ Changes in vital parameters and laboratory investigations. Timepoint: Day 0 to Day 7 | — |
Countries
India
Contacts
Public ContactSri HSrinivas
Venkat Pharma
Outcome results
None listed